Collegium Pharmaceutical, Inc. (COLL)

NASDAQ: COLL · Real-Time Price · USD

29.56

+0.67 (2.32%)

At close: May 12, 2025, 4:00 PM

28.89

-0.67 (-2.27%)

After-hours: May 12, 2025, 4:51 PM EDT

Collegium Pharmaceutical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	664.28	631.45	566.77	463.93	276.87	310.02	Upgrade
Revenue Growth (YoY)	17.17%	11.41%	22.17%	67.56%	-10.69%	4.49%	Upgrade
Cost of Revenue	86.07	83.53	79.72	118.19	59.07	69.5	Upgrade
Gross Profit	578.22	547.92	487.05	345.74	217.8	240.52	Upgrade
Selling, General & Admin	217.42	182.98	150.71	172.19	118.96	113.83	Upgrade
Research & Development	-	-	-	3.98	9.45	9.77	Upgrade
Operating Expenses	403.68	348.29	296.47	307.64	195.59	184.28	Upgrade
Operating Income	174.53	199.63	190.58	38.11	22.21	56.23	Upgrade
Interest Expense	-77.43	-73.97	-83.34	-63.21	-21.01	-28.88	Upgrade
Interest & Investment Income	11.71	13.98	15.62	1.05	0.01	0.23	Upgrade
EBT Excluding Unusual Items	108.82	139.63	122.85	-24.06	1.2	27.58	Upgrade
Merger & Restructuring Charges	-33.08	-29.6	-15.12	-	-4.58	-	Upgrade
Asset Writedown	-	-	-	-4.79	-	-	Upgrade
Legal Settlements	-	-	-8.5	-	-	-	Upgrade
Other Unusual Items	-10.68	-11.47	-23.5	-	-	-	Upgrade
Pretax Income	65.07	98.57	75.73	-28.85	-3.37	27.58	Upgrade
Income Tax Expense	21.17	29.38	27.58	-3.85	-74.89	0.83	Upgrade
Net Income	43.89	69.19	48.16	-25	71.52	26.75	Upgrade
Net Income to Common	43.89	69.19	48.16	-25	71.52	26.75	Upgrade
Net Income Growth	-52.95%	43.68%	-	-	167.33%	-	Upgrade
Shares Outstanding (Basic)	32	32	34	34	35	34	Upgrade
Shares Outstanding (Diluted)	38	40	42	34	41	35	Upgrade
Shares Change (YoY)	-12.15%	-3.26%	23.53%	-17.58%	16.77%	5.07%	Upgrade
EPS (Basic)	1.37	2.14	1.43	-0.74	2.05	0.78	Upgrade
EPS (Diluted)	1.25	1.86	1.29	-0.74	1.86	0.76	Upgrade
EPS Growth	-45.82%	43.56%	-	-	144.25%	-	Upgrade
Free Cash Flow	196.56	203.33	274.29	122.61	101.61	88.4	Upgrade
Free Cash Flow Per Share	5.13	5.03	6.56	3.62	2.48	2.52	Upgrade
Gross Margin	87.04%	86.77%	85.93%	74.52%	78.66%	77.58%	Upgrade
Operating Margin	26.27%	31.61%	33.63%	8.21%	8.02%	18.14%	Upgrade
Profit Margin	6.61%	10.96%	8.50%	-5.39%	25.83%	8.63%	Upgrade
Free Cash Flow Margin	29.59%	32.20%	48.39%	26.43%	36.70%	28.51%	Upgrade
EBITDA	364.82	368.79	339.83	172.26	91.12	117.78	Upgrade
EBITDA Margin	54.92%	58.40%	59.96%	37.13%	32.91%	37.99%	Upgrade
D&A For EBITDA	190.29	169.16	149.26	134.15	68.92	61.55	Upgrade
EBIT	174.53	199.63	190.58	38.11	22.21	56.23	Upgrade
EBIT Margin	26.27%	31.61%	33.63%	8.21%	8.02%	18.14%	Upgrade
Effective Tax Rate	32.54%	29.80%	36.41%	-	-	3.01%	Upgrade
Advertising Expenses	-	10.66	7.41	11.74	4.19	5.37	Upgrade

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q